Irish firm’s cutting-edge pet drugs have potential for human use | Business Post

Louise Grubb chief executive of Trivium Vet: ‘The actual disease of HCM in cats is a model of what it’s like in humans, for which there isn’t a very effective treatment.’ Picture: Colin Shanahan

The company was founded in 2015 by Louise Grubb, who previously founded pharma storage company Q1 Scientific, as well as Tom Brennan, whose EirGen Pharma was bought by Opko Health in 2015 for around €120 million. “The actual disease of HCM in cats is a model of what it’s like in humans, for which there isn’t a very effective treatment,” Grubb said.

“We’ve . . . really valuable research done in dogs and cats, and we think we can use that to help in the human sphere,” Grubb said.TriviumVet, which has backing from Enterprise Ireland and employs 12 people, did not initially intend to move into the sphere of human healthcare, Grubb said. The original plan – which still stands today, and is developing all the time – was to examine diseases in cats and dogs for which there was no effective treatment, and to plug that gap.

Colombia Últimas Noticias, Colombia Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Subsidised companies and dividends, consumer sentiment falls, and crypto oversightSubsidised companies and dividends, consumer sentiment falls, and crypto oversight via IrishTimesBiz
Fuente: IrishTimesBiz - 🏆 6. / 77 Leer más »